Skip to main content
Top
Published in: Critical Care 1/2014

Open Access 01-02-2014 | Review

Heart–kidney crosstalk and role of humoral signaling in critical illness

Authors: Grazia Maria Virzì, Sonya Day, Massimo de Cal, Giorgio Vescovo, Claudio Ronco

Published in: Critical Care | Issue 1/2014

Login to get access

Abstract

Organ failure in the heart or kidney can initiate various complex metabolic, cell-mediated and humoral pathways affecting distant organs, contributing to the high therapeutic costs and significantly higher morbidity and mortality. The universal outreach of cells in an injured state has myriad consequences to distant organ cells and their milieu. Heart performance and kidney function are closely interconnected and communication between these organs occurs through a variety of bidirectional pathways. The term cardiorenal syndrome (CRS) is often used to describe this condition and represents an important model for exploring the pathophysiology of cardiac and renal dysfunction. Clinical evidence suggests that tissue injury in both acute kidney injury and heart failure has immune-mediated inflammatory consequences that can initiate remote organ dysfunction. Acute cardiorenal syndrome (CRS type 1) and acute renocardiac syndrome (CRS type 3) are particularly relevant in high-acuity medical units. This review briefly summarizes relevant research and focuses on the role of signaling in heart–kidney crosstalk in the critical care setting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol. 2008, 52: 1527-1539. 10.1016/j.jacc.2008.07.051.PubMed Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol. 2008, 52: 1527-1539. 10.1016/j.jacc.2008.07.051.PubMed
2.
go back to reference Goh CY, Vizzi G, De Cal M, Ronco C: Cardiorenal syndrome: a complex series of combined heart/kidney disorders. Contrib Nephrol. 2011, 174: 33-45.PubMed Goh CY, Vizzi G, De Cal M, Ronco C: Cardiorenal syndrome: a complex series of combined heart/kidney disorders. Contrib Nephrol. 2011, 174: 33-45.PubMed
3.
go back to reference McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, Cruz D, House AA, Schmidt-Ott KM, Vescovo G, Bagshaw SM, Hoste EA, Briguori C, Braam B, Chawla LS, Costanzo MR, Tumlin JA, Herzog CA, Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C: Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol. 2013, 182: 82-98.PubMed McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, Cruz D, House AA, Schmidt-Ott KM, Vescovo G, Bagshaw SM, Hoste EA, Briguori C, Braam B, Chawla LS, Costanzo MR, Tumlin JA, Herzog CA, Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C: Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol. 2013, 182: 82-98.PubMed
4.
go back to reference Bagshaw SM, Cruz DN, Aspromonte N, Daliento L, Ronco F, Sheinfeld G, Anker SD, Anand I, Bellomo R, Berl T, Bobek I, Davenport A, Haapio M, Hillege H, House A, Katz N, Maisel A, Mankad S, McCullough P, Mebazaa A, Palazzuoli A, Ponikowski P, Shaw A, Soni S, Vescovo G, Zamperetti N, Zanco P, Ronco C: Acute dialysis quality initiative consensus group: epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference. Nephrol Dial Transplant. 2010, 25: 1406-1416. 10.1093/ndt/gfq066.PubMed Bagshaw SM, Cruz DN, Aspromonte N, Daliento L, Ronco F, Sheinfeld G, Anker SD, Anand I, Bellomo R, Berl T, Bobek I, Davenport A, Haapio M, Hillege H, House A, Katz N, Maisel A, Mankad S, McCullough P, Mebazaa A, Palazzuoli A, Ponikowski P, Shaw A, Soni S, Vescovo G, Zamperetti N, Zanco P, Ronco C: Acute dialysis quality initiative consensus group: epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference. Nephrol Dial Transplant. 2010, 25: 1406-1416. 10.1093/ndt/gfq066.PubMed
5.
go back to reference Grams ME, Rabb H: The distant organ effects of acute kidney injury. Kidney Int. 2012, 81: 942-948. 10.1038/ki.2011.241.PubMed Grams ME, Rabb H: The distant organ effects of acute kidney injury. Kidney Int. 2012, 81: 942-948. 10.1038/ki.2011.241.PubMed
6.
go back to reference Okusa MD: The changing pattern of acute kidney injury: from one to multiple organ failure. Contrib Nephrol. 2010, 165: 153-158.PubMed Okusa MD: The changing pattern of acute kidney injury: from one to multiple organ failure. Contrib Nephrol. 2010, 165: 153-158.PubMed
7.
go back to reference Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005, 294: 813-818. 10.1001/jama.294.7.813.PubMed Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005, 294: 813-818. 10.1001/jama.294.7.813.PubMed
8.
go back to reference Lameire N, Van Biesen W, Vanholder R: The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol. 2006, 2: 364-377.PubMed Lameire N, Van Biesen W, Vanholder R: The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol. 2006, 2: 364-377.PubMed
9.
go back to reference Waikar SS, Liu KD, Chertow GM: The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens. 2007, 16: 227-236. 10.1097/MNH.0b013e3280dd8c35.PubMedCentralPubMed Waikar SS, Liu KD, Chertow GM: The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens. 2007, 16: 227-236. 10.1097/MNH.0b013e3280dd8c35.PubMedCentralPubMed
10.
go back to reference Esson ML, Schrier RW: Diagnosis and treatment of acute tubular necrosis. Ann Intern Med. 2002, 137: 744-752. 10.7326/0003-4819-137-9-200211050-00010.PubMed Esson ML, Schrier RW: Diagnosis and treatment of acute tubular necrosis. Ann Intern Med. 2002, 137: 744-752. 10.7326/0003-4819-137-9-200211050-00010.PubMed
11.
go back to reference Palevsky PM: Renal replacement therapy in acute kidney injury. Adv Chronic Kidney Dis. 2013, 20: 76-84. 10.1053/j.ackd.2012.09.004.PubMedCentralPubMed Palevsky PM: Renal replacement therapy in acute kidney injury. Adv Chronic Kidney Dis. 2013, 20: 76-84. 10.1053/j.ackd.2012.09.004.PubMedCentralPubMed
12.
go back to reference Kelly KJ, Molitoris BA: Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol. 2000, 20: 4-19.PubMed Kelly KJ, Molitoris BA: Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol. 2000, 20: 4-19.PubMed
13.
go back to reference Yap SC, Lee HT: Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology. 2012, 116: 1139-1148. 10.1097/ALN.0b013e31824f951b.PubMed Yap SC, Lee HT: Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology. 2012, 116: 1139-1148. 10.1097/ALN.0b013e31824f951b.PubMed
14.
go back to reference Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996, 275: 1489-1494. 10.1001/jama.1996.03530430033035.PubMed Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996, 275: 1489-1494. 10.1001/jama.1996.03530430033035.PubMed
15.
go back to reference White LE, Hassoun HT: Inflammatory mechanisms of organ crosstalk during ischemic acute kidney injury. Int J Nephrol. 2012, 2012: 505197-PubMedCentralPubMed White LE, Hassoun HT: Inflammatory mechanisms of organ crosstalk during ischemic acute kidney injury. Int J Nephrol. 2012, 2012: 505197-PubMedCentralPubMed
16.
go back to reference Ko GJ, Rabb H, Hassoun HT: Kidney–lung crosstalk in the critically ill patient. Blood Purif. 2009, 28: 75-83. 10.1159/000218087.PubMedCentralPubMed Ko GJ, Rabb H, Hassoun HT: Kidney–lung crosstalk in the critically ill patient. Blood Purif. 2009, 28: 75-83. 10.1159/000218087.PubMedCentralPubMed
17.
go back to reference Basu RK, Wheeler DS: Kidney–lung cross-talk and acute kidney injury. Pediatr Nephrol. 2013, Epub ahead of print Basu RK, Wheeler DS: Kidney–lung cross-talk and acute kidney injury. Pediatr Nephrol. 2013, Epub ahead of print
18.
go back to reference Singbartl K: Renal–pulmonary crosstalk. Contrib Nephrol. 2011, 174: 65-70.PubMed Singbartl K: Renal–pulmonary crosstalk. Contrib Nephrol. 2011, 174: 65-70.PubMed
19.
go back to reference Sural S, Sharma RK, Gupta A, Sharma AP, Gulati S: Acute renal failure associated with liver disease in India: etiology and outcome. Ren Fail. 2000, 22: 623-634. 10.1081/JDI-100100903.PubMed Sural S, Sharma RK, Gupta A, Sharma AP, Gulati S: Acute renal failure associated with liver disease in India: etiology and outcome. Ren Fail. 2000, 22: 623-634. 10.1081/JDI-100100903.PubMed
20.
go back to reference Serteser M, Koken T, Kahraman A, Yilmaz K, Akbulut G, Dilek ON: Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia/reperfusion injury in mice. J Surg Res. 2002, 107: 234-240. 10.1006/jsre.2002.6513.PubMed Serteser M, Koken T, Kahraman A, Yilmaz K, Akbulut G, Dilek ON: Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia/reperfusion injury in mice. J Surg Res. 2002, 107: 234-240. 10.1006/jsre.2002.6513.PubMed
21.
go back to reference Canbay A, Friedman S, Gores GJ: Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004, 39: 273-278. 10.1002/hep.20051.PubMed Canbay A, Friedman S, Gores GJ: Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004, 39: 273-278. 10.1002/hep.20051.PubMed
22.
go back to reference Jaeschke H: Inflammation in response to hepatocellular apoptosis. Hepatology. 2002, 35: 964-966. 10.1053/jhep.2002.0350964.PubMed Jaeschke H: Inflammation in response to hepatocellular apoptosis. Hepatology. 2002, 35: 964-966. 10.1053/jhep.2002.0350964.PubMed
23.
go back to reference White LE, Chaudhary R, Moore LJ, Moore FA, Hassoun HT: Surgical sepsis and organ crosstalk: the role of the kidney. J Surg Res. 2011, 167: 306-315. 10.1016/j.jss.2010.11.923.PubMedCentralPubMed White LE, Chaudhary R, Moore LJ, Moore FA, Hassoun HT: Surgical sepsis and organ crosstalk: the role of the kidney. J Surg Res. 2011, 167: 306-315. 10.1016/j.jss.2010.11.923.PubMedCentralPubMed
24.
go back to reference Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS: Hepatorenal syndrome: the 8th international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2012, 16: R23-10.1186/cc11188.PubMedCentralPubMed Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS: Hepatorenal syndrome: the 8th international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2012, 16: R23-10.1186/cc11188.PubMedCentralPubMed
25.
go back to reference Angeli P, Morando F, Cavallin M, Piano S: Hepatorenal syndrome. Contrib Nephrol. 2011, 174: 46-55.PubMed Angeli P, Morando F, Cavallin M, Piano S: Hepatorenal syndrome. Contrib Nephrol. 2011, 174: 46-55.PubMed
26.
go back to reference Brouns R, De Deyn PP: Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004, 107: 1-16. 10.1016/j.clineuro.2004.07.012.PubMed Brouns R, De Deyn PP: Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004, 107: 1-16. 10.1016/j.clineuro.2004.07.012.PubMed
27.
go back to reference Li X, Hassoun HT, Santora R, Rabb H: Organ crosstalk: the role of the kidney. Curr Opin Crit Care. 2009, 15: 481-487. 10.1097/MCC.0b013e328332f69e.PubMed Li X, Hassoun HT, Santora R, Rabb H: Organ crosstalk: the role of the kidney. Curr Opin Crit Care. 2009, 15: 481-487. 10.1097/MCC.0b013e328332f69e.PubMed
28.
go back to reference Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, Crow M, Ross CA, Mattson MP, Rabb H: Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol. 2008, 19: 1360-1370. 10.1681/ASN.2007080901.PubMedCentralPubMed Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, Crow M, Ross CA, Mattson MP, Rabb H: Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol. 2008, 19: 1360-1370. 10.1681/ASN.2007080901.PubMedCentralPubMed
29.
go back to reference Kinsey GR, Li L, Okusa MD: Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008, 109: e102-e107. 10.1159/000142934.PubMedCentralPubMed Kinsey GR, Li L, Okusa MD: Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008, 109: e102-e107. 10.1159/000142934.PubMedCentralPubMed
30.
go back to reference Kelly KJ: Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol. 2003, 14: 1549-1558. 10.1097/01.ASN.0000064946.94590.46.PubMed Kelly KJ: Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol. 2003, 14: 1549-1558. 10.1097/01.ASN.0000064946.94590.46.PubMed
31.
go back to reference Gill R, Tsung A, Billiar T: Linking oxidative stress to inflammation: toll-like receptors. Free Radic Biol Med. 2010, 48: 1121-1132. 10.1016/j.freeradbiomed.2010.01.006.PubMedCentralPubMed Gill R, Tsung A, Billiar T: Linking oxidative stress to inflammation: toll-like receptors. Free Radic Biol Med. 2010, 48: 1121-1132. 10.1016/j.freeradbiomed.2010.01.006.PubMedCentralPubMed
32.
go back to reference Feltes CM, Van Eyk J, Rabb H: Distant-organ changes after acute kidney injury. Nephron Physiol. 2008, 109: p80-p84. 10.1159/000142940.PubMed Feltes CM, Van Eyk J, Rabb H: Distant-organ changes after acute kidney injury. Nephron Physiol. 2008, 109: p80-p84. 10.1159/000142940.PubMed
33.
go back to reference Molls RR, Rabb H: Limiting deleterious cross-talk between failing organs. Crit Care Med. 2004, 32: 2358-2359.PubMed Molls RR, Rabb H: Limiting deleterious cross-talk between failing organs. Crit Care Med. 2004, 32: 2358-2359.PubMed
34.
go back to reference Paladino JD, Hotchkiss JR, Rabb H: Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease?. Microvasc Res. 2009, 77: 8-12. 10.1016/j.mvr.2008.09.001.PubMedCentralPubMed Paladino JD, Hotchkiss JR, Rabb H: Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease?. Microvasc Res. 2009, 77: 8-12. 10.1016/j.mvr.2008.09.001.PubMedCentralPubMed
35.
go back to reference Waeckerle-Men Y, Starke A, Wuthrich RP: PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Nephrol Dial Transplant. 2007, 22: 1527-1536. 10.1093/ndt/gfl818.PubMed Waeckerle-Men Y, Starke A, Wuthrich RP: PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Nephrol Dial Transplant. 2007, 22: 1527-1536. 10.1093/ndt/gfl818.PubMed
36.
go back to reference Waeckerle-Men Y, Starke A, Wahl PR, Wuthrich RP: Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation. Kidney Blood Press Res. 2007, 30: 421-429. 10.1159/000110578.PubMed Waeckerle-Men Y, Starke A, Wahl PR, Wuthrich RP: Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation. Kidney Blood Press Res. 2007, 30: 421-429. 10.1159/000110578.PubMed
37.
go back to reference Jevnikar AM, Brennan DC, Singer GG, Heng JE, Maslinski W, Wuthrich RP, Glimcher LH, Kelley VE: Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int. 1991, 40: 203-211. 10.1038/ki.1991.201.PubMed Jevnikar AM, Brennan DC, Singer GG, Heng JE, Maslinski W, Wuthrich RP, Glimcher LH, Kelley VE: Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int. 1991, 40: 203-211. 10.1038/ki.1991.201.PubMed
38.
go back to reference Schmouder RL, Strieter RM, Wiggins RC, Chensue SW, Kunkel SL: In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int. 1992, 41: 191-198. 10.1038/ki.1992.26.PubMed Schmouder RL, Strieter RM, Wiggins RC, Chensue SW, Kunkel SL: In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int. 1992, 41: 191-198. 10.1038/ki.1992.26.PubMed
39.
go back to reference Nechemia-Arbely Y, Barkan D, Pizov G, Shriki A, Rose-John S, Galun E, Axelrod JH: IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol. 2008, 19: 1106-1115. 10.1681/ASN.2007070744.PubMedCentralPubMed Nechemia-Arbely Y, Barkan D, Pizov G, Shriki A, Rose-John S, Galun E, Axelrod JH: IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol. 2008, 19: 1106-1115. 10.1681/ASN.2007070744.PubMedCentralPubMed
40.
go back to reference Pontrelli P, Ursi M, Ranieri E, Capobianco C, Schena FP, Gesualdo L, Grandaliano G: CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. J Am Soc Nephrol. 2006, 17: 627-636. 10.1681/ASN.2005020202.PubMed Pontrelli P, Ursi M, Ranieri E, Capobianco C, Schena FP, Gesualdo L, Grandaliano G: CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. J Am Soc Nephrol. 2006, 17: 627-636. 10.1681/ASN.2005020202.PubMed
41.
go back to reference van Kooten C, Gerritsma JS, Paape ME, van Es LA, Banchereau J, Daha MR: Possible role for CD40–CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int. 1997, 51: 711-721. 10.1038/ki.1997.102.PubMed van Kooten C, Gerritsma JS, Paape ME, van Es LA, Banchereau J, Daha MR: Possible role for CD40–CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int. 1997, 51: 711-721. 10.1038/ki.1997.102.PubMed
42.
go back to reference Li H, Nord EP: CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells. Am J Physiol Renal Physiol. 2002, 282: F1020-F1033.PubMed Li H, Nord EP: CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells. Am J Physiol Renal Physiol. 2002, 282: F1020-F1033.PubMed
43.
go back to reference Gerritsma JS, van Kooten C, Gerritsen AF, van Es LA, Daha MR: Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int. 1998, 53: 609-616. 10.1046/j.1523-1755.1998.00799.x.PubMed Gerritsma JS, van Kooten C, Gerritsen AF, van Es LA, Daha MR: Transforming growth factor-beta 1 regulates chemokine and complement production by human proximal tubular epithelial cells. Kidney Int. 1998, 53: 609-616. 10.1046/j.1523-1755.1998.00799.x.PubMed
44.
go back to reference van Kooten C, Woltman AM, Daha MR: Immunological function of tubular epithelial cells: the functional implications of CD40 expression. Exp Nephrol. 2000, 8: 203-207. 10.1159/000020669.PubMed van Kooten C, Woltman AM, Daha MR: Immunological function of tubular epithelial cells: the functional implications of CD40 expression. Exp Nephrol. 2000, 8: 203-207. 10.1159/000020669.PubMed
45.
go back to reference Laxmanan S, Datta D, Geehan C, Briscoe DM, Pal S: CD40: a mediator of pro- and anti-inflammatory signals in renal tubular epithelial cells. J Am Soc Nephrol. 2005, 16: 2714-2723. 10.1681/ASN.2005010045.PubMed Laxmanan S, Datta D, Geehan C, Briscoe DM, Pal S: CD40: a mediator of pro- and anti-inflammatory signals in renal tubular epithelial cells. J Am Soc Nephrol. 2005, 16: 2714-2723. 10.1681/ASN.2005010045.PubMed
46.
go back to reference Akcay A, Nguyen Q, Edelstein CL: Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009, 2009: 137072-PubMedCentralPubMed Akcay A, Nguyen Q, Edelstein CL: Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009, 2009: 137072-PubMedCentralPubMed
47.
go back to reference Schober A, Zernecke A: Chemokines in vascular remodeling. Thromb Haemost. 2007, 97: 730-737.PubMed Schober A, Zernecke A: Chemokines in vascular remodeling. Thromb Haemost. 2007, 97: 730-737.PubMed
48.
go back to reference Mann DL: Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002, 91: 988-998. 10.1161/01.RES.0000043825.01705.1B.PubMed Mann DL: Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002, 91: 988-998. 10.1161/01.RES.0000043825.01705.1B.PubMed
49.
go back to reference Paulus WJ: Cytokines and heart failure. Heart Fail Monit. 2000, 1: 50-56.PubMed Paulus WJ: Cytokines and heart failure. Heart Fail Monit. 2000, 1: 50-56.PubMed
50.
go back to reference Ramesh G, Reeves WB: Inflammatory cytokines in acute renal failure. Kidney Int Suppl. 2004, 91: S56-S61.PubMed Ramesh G, Reeves WB: Inflammatory cytokines in acute renal failure. Kidney Int Suppl. 2004, 91: S56-S61.PubMed
51.
go back to reference Camussi G, Deregibus MC, Cantaluppi V: Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans. 2013, 41: 283-287. 10.1042/BST20120192.PubMed Camussi G, Deregibus MC, Cantaluppi V: Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans. 2013, 41: 283-287. 10.1042/BST20120192.PubMed
52.
go back to reference Struthers AD: Pathophysiology of heart failure following myocardial infarction. Heart. 2005, 91: ii14-ii16. 10.1136/hrt.2004.049122. discussion ii31, ii43-ii48PubMedCentralPubMed Struthers AD: Pathophysiology of heart failure following myocardial infarction. Heart. 2005, 91: ii14-ii16. 10.1136/hrt.2004.049122. discussion ii31, ii43-ii48PubMedCentralPubMed
53.
go back to reference Wang Y, John R, Chen J, Richardson JA, Shelton JM, Bennett M, Zhou XJ, Nagami GT, Zhang Y, Wu QQ, Lu CY: IRF-1 promotes inflammation early after ischemic acute kidney injury. J Am Soc Nephrol. 2009, 20: 1544-1555. 10.1681/ASN.2008080843.PubMedCentralPubMed Wang Y, John R, Chen J, Richardson JA, Shelton JM, Bennett M, Zhou XJ, Nagami GT, Zhang Y, Wu QQ, Lu CY: IRF-1 promotes inflammation early after ischemic acute kidney injury. J Am Soc Nephrol. 2009, 20: 1544-1555. 10.1681/ASN.2008080843.PubMedCentralPubMed
54.
go back to reference Healy S, Khan DH, Davie JR: Gene expression regulation through 14-3-3 interactions with histones and HDACs. Discov Med. 2011, 11: 349-358.PubMed Healy S, Khan DH, Davie JR: Gene expression regulation through 14-3-3 interactions with histones and HDACs. Discov Med. 2011, 11: 349-358.PubMed
55.
go back to reference Banerjee T, Chakravarti D: A peek into the complex realm of histone phosphorylation. Mol Cell Biol. 2011, 31: 4858-4873. 10.1128/MCB.05631-11.PubMedCentralPubMed Banerjee T, Chakravarti D: A peek into the complex realm of histone phosphorylation. Mol Cell Biol. 2011, 31: 4858-4873. 10.1128/MCB.05631-11.PubMedCentralPubMed
56.
go back to reference Zager RA, Johnson AC: Renal ischemia–reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol. 2009, 296: F1032-F1041. 10.1152/ajprenal.00061.2009.PubMedCentralPubMed Zager RA, Johnson AC: Renal ischemia–reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol. 2009, 296: F1032-F1041. 10.1152/ajprenal.00061.2009.PubMedCentralPubMed
57.
go back to reference Zager RA, Johnson AC: Progressive histone alterations and proinflammatory gene activation: consequences of heme protein/iron-mediated proximal tubule injury. Am J Physiol Renal Physiol. 2010, 298: F827-F837. 10.1152/ajprenal.00683.2009.PubMedCentralPubMed Zager RA, Johnson AC: Progressive histone alterations and proinflammatory gene activation: consequences of heme protein/iron-mediated proximal tubule injury. Am J Physiol Renal Physiol. 2010, 298: F827-F837. 10.1152/ajprenal.00683.2009.PubMedCentralPubMed
58.
go back to reference Zager RA: 'Biologic memory' in response to acute kidney injury: cytoresistance, toll-like receptor hyper-responsiveness and the onset of progressive renal disease. Nephrol Dial Transplant. 2013, 28: 1985-1993. 10.1093/ndt/gft101.PubMedCentralPubMed Zager RA: 'Biologic memory' in response to acute kidney injury: cytoresistance, toll-like receptor hyper-responsiveness and the onset of progressive renal disease. Nephrol Dial Transplant. 2013, 28: 1985-1993. 10.1093/ndt/gft101.PubMedCentralPubMed
59.
go back to reference Allam R, Scherbaum CR, Darisipudi MN, Mulay SR, Hagele H, Lichtnekert J, Hagemann JH, Rupanagudi KV, Ryu M, Schwarzenberger C, Hohenstein B, Hugo C, Uhl B, Reichel CA, Krombach F, Monestier M, Liapis H, Moreth K, Schaefer L, Anders HJ: Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol. 2012, 23: 1375-1388. 10.1681/ASN.2011111077.PubMedCentralPubMed Allam R, Scherbaum CR, Darisipudi MN, Mulay SR, Hagele H, Lichtnekert J, Hagemann JH, Rupanagudi KV, Ryu M, Schwarzenberger C, Hohenstein B, Hugo C, Uhl B, Reichel CA, Krombach F, Monestier M, Liapis H, Moreth K, Schaefer L, Anders HJ: Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol. 2012, 23: 1375-1388. 10.1681/ASN.2011111077.PubMedCentralPubMed
60.
go back to reference Molitoris BA, Sutton TA: Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int. 2004, 66: 496-499. 10.1111/j.1523-1755.2004.761_5.x.PubMed Molitoris BA, Sutton TA: Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int. 2004, 66: 496-499. 10.1111/j.1523-1755.2004.761_5.x.PubMed
61.
go back to reference Ascon DB, Lopez-Briones S, Liu M, Ascon M, Savransky V, Colvin RB, Soloski MJ, Rabb H: Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol. 2006, 177: 3380-3387.PubMed Ascon DB, Lopez-Briones S, Liu M, Ascon M, Savransky V, Colvin RB, Soloski MJ, Rabb H: Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol. 2006, 177: 3380-3387.PubMed
62.
go back to reference Linas SL, Whittenburg D, Parsons PE, Repine JE: Ischemia increases neutrophil retention and worsens acute renal failure: role of oxygen metabolites and ICAM 1. Kidney Int. 1995, 48: 1584-1591. 10.1038/ki.1995.451.PubMed Linas SL, Whittenburg D, Parsons PE, Repine JE: Ischemia increases neutrophil retention and worsens acute renal failure: role of oxygen metabolites and ICAM 1. Kidney Int. 1995, 48: 1584-1591. 10.1038/ki.1995.451.PubMed
63.
go back to reference Kluth DC, Erwig LP, Rees AJ: Multiple facets of macrophages in renal injury. Kidney Int. 2004, 66: 542-557. 10.1111/j.1523-1755.2004.00773.x.PubMed Kluth DC, Erwig LP, Rees AJ: Multiple facets of macrophages in renal injury. Kidney Int. 2004, 66: 542-557. 10.1111/j.1523-1755.2004.00773.x.PubMed
64.
go back to reference Wang W, Reeves WB, Ramesh G: Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol. 2008, 294: F739-F747. 10.1152/ajprenal.00508.2007.PubMedCentralPubMed Wang W, Reeves WB, Ramesh G: Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol. 2008, 294: F739-F747. 10.1152/ajprenal.00508.2007.PubMedCentralPubMed
65.
go back to reference Bradford D, Cole SJ, Cooper HM: Netrin-1: diversity in development. Int J Biochem Cell Biol. 2009, 41: 487-493. 10.1016/j.biocel.2008.03.014.PubMed Bradford D, Cole SJ, Cooper HM: Netrin-1: diversity in development. Int J Biochem Cell Biol. 2009, 41: 487-493. 10.1016/j.biocel.2008.03.014.PubMed
66.
go back to reference Lien YH, Yong KC, Cho C, Igarashi S, Lai LW: S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int. 2006, 69: 1601-1608. 10.1038/sj.ki.5000360.PubMed Lien YH, Yong KC, Cho C, Igarashi S, Lai LW: S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int. 2006, 69: 1601-1608. 10.1038/sj.ki.5000360.PubMed
67.
go back to reference Kelly KJ, Williams WW, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996, 97: 1056-1063. 10.1172/JCI118498.PubMedCentralPubMed Kelly KJ, Williams WW, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996, 97: 1056-1063. 10.1172/JCI118498.PubMedCentralPubMed
68.
go back to reference Shalhoub J, Falck-Hansen MA, Davies AH, Monaco C: Innate immunity and monocyte–macrophage activation in atherosclerosis. J Inflamm (Lond). 2011, 8: 9-10.1186/1476-9255-8-9. Shalhoub J, Falck-Hansen MA, Davies AH, Monaco C: Innate immunity and monocyte–macrophage activation in atherosclerosis. J Inflamm (Lond). 2011, 8: 9-10.1186/1476-9255-8-9.
69.
go back to reference Mogensen TH: Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009, 22: 240-273. 10.1128/CMR.00046-08.PubMedCentralPubMed Mogensen TH: Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009, 22: 240-273. 10.1128/CMR.00046-08.PubMedCentralPubMed
70.
go back to reference Rabb H: The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int. 2002, 61: 1935-1946. 10.1046/j.1523-1755.2002.00378.x.PubMed Rabb H: The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int. 2002, 61: 1935-1946. 10.1046/j.1523-1755.2002.00378.x.PubMed
71.
go back to reference Chakraborti T, Mandal A, Mandal M, Das S, Chakraborti S: Complement activation in heart diseases. Role of oxidants. Cell Signal. 2000, 12: 607-617. 10.1016/S0898-6568(00)00111-X.PubMed Chakraborti T, Mandal A, Mandal M, Das S, Chakraborti S: Complement activation in heart diseases. Role of oxidants. Cell Signal. 2000, 12: 607-617. 10.1016/S0898-6568(00)00111-X.PubMed
72.
go back to reference Hochegger K, Schatz T, Eller P, Tagwerker A, Heininger D, Mayer G, Rosenkranz AR: Role of alpha/beta and gamma/delta T cells in renal ischemia–reperfusion injury. Am J Physiol Renal Physiol. 2007, 293: F741-F747. 10.1152/ajprenal.00486.2006.PubMed Hochegger K, Schatz T, Eller P, Tagwerker A, Heininger D, Mayer G, Rosenkranz AR: Role of alpha/beta and gamma/delta T cells in renal ischemia–reperfusion injury. Am J Physiol Renal Physiol. 2007, 293: F741-F747. 10.1152/ajprenal.00486.2006.PubMed
73.
go back to reference Silverstein DM: Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2009, 24: 1445-1452. 10.1007/s00467-008-1046-0.PubMed Silverstein DM: Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2009, 24: 1445-1452. 10.1007/s00467-008-1046-0.PubMed
74.
go back to reference Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, Wang Y, Wu QQ, Hartono JR, Winterberg PD, Lu CY: Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int. 2011, 79: 288-299. 10.1038/ki.2010.381.PubMedCentralPubMed Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, Wang Y, Wu QQ, Hartono JR, Winterberg PD, Lu CY: Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int. 2011, 79: 288-299. 10.1038/ki.2010.381.PubMedCentralPubMed
75.
go back to reference Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006, 17: 1503-1520. 10.1681/ASN.2006010017.PubMed Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006, 17: 1503-1520. 10.1681/ASN.2006010017.PubMed
76.
go back to reference Sutton TA: Alteration of microvascular permeability in acute kidney injury. Microvasc Res. 2009, 77: 4-7. 10.1016/j.mvr.2008.09.004.PubMedCentralPubMed Sutton TA: Alteration of microvascular permeability in acute kidney injury. Microvasc Res. 2009, 77: 4-7. 10.1016/j.mvr.2008.09.004.PubMedCentralPubMed
77.
go back to reference Givertz MM, Colucci WS: New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet. 1998, 352: SI34-SI38.PubMed Givertz MM, Colucci WS: New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet. 1998, 352: SI34-SI38.PubMed
78.
go back to reference Chuasuwan A, Kellum JA: Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment. Semin Nephrol. 2012, 32: 31-39. 10.1016/j.semnephrol.2011.11.005.PubMed Chuasuwan A, Kellum JA: Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment. Semin Nephrol. 2012, 32: 31-39. 10.1016/j.semnephrol.2011.11.005.PubMed
79.
go back to reference Okusa MD, Li L: Dendritic cells in acute kidney injury: cues from the microenvironment. Trans Am Clin Climatol Assoc. 2012, 123: 54-62. discussion 62–63PubMedCentralPubMed Okusa MD, Li L: Dendritic cells in acute kidney injury: cues from the microenvironment. Trans Am Clin Climatol Assoc. 2012, 123: 54-62. discussion 62–63PubMedCentralPubMed
80.
go back to reference Kinsey GR, Okusa MD: Role of leukocytes in the pathogenesis of acute kidney injury. Crit Care. 2012, 16: 214-10.1186/cc11228.PubMedCentralPubMed Kinsey GR, Okusa MD: Role of leukocytes in the pathogenesis of acute kidney injury. Crit Care. 2012, 16: 214-10.1186/cc11228.PubMedCentralPubMed
81.
go back to reference Kaissling B, Le Hir M: Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int. 1994, 45: 709-720. 10.1038/ki.1994.95.PubMed Kaissling B, Le Hir M: Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int. 1994, 45: 709-720. 10.1038/ki.1994.95.PubMed
82.
go back to reference Rosner MH, Ronco C, Okusa MD: The role of inflammation in the cardio-renal syndrome: a focus on cytokines and inflammatory mediators. Semin Nephrol. 2012, 32: 70-78. 10.1016/j.semnephrol.2011.11.010.PubMed Rosner MH, Ronco C, Okusa MD: The role of inflammation in the cardio-renal syndrome: a focus on cytokines and inflammatory mediators. Semin Nephrol. 2012, 32: 70-78. 10.1016/j.semnephrol.2011.11.010.PubMed
83.
go back to reference Dong X, Swaminathan S, Bachman LA, Croatt AJ, Nath KA, Griffin MD: Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 2007, 71: 619-628. 10.1038/sj.ki.5002132.PubMed Dong X, Swaminathan S, Bachman LA, Croatt AJ, Nath KA, Griffin MD: Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 2007, 71: 619-628. 10.1038/sj.ki.5002132.PubMed
84.
go back to reference Li L, Okusa MD: Macrophages, dendritic cells, and kidney ischemia–reperfusion injury. Semin Nephrol. 2010, 30: 268-277. 10.1016/j.semnephrol.2010.03.005.PubMedCentralPubMed Li L, Okusa MD: Macrophages, dendritic cells, and kidney ischemia–reperfusion injury. Semin Nephrol. 2010, 30: 268-277. 10.1016/j.semnephrol.2010.03.005.PubMedCentralPubMed
85.
go back to reference Tadagavadi RK, Reeves WB: Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J Am Soc Nephrol. 2010, 21: 53-63. 10.1681/ASN.2009040407.PubMedCentralPubMed Tadagavadi RK, Reeves WB: Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J Am Soc Nephrol. 2010, 21: 53-63. 10.1681/ASN.2009040407.PubMedCentralPubMed
86.
go back to reference Benoist C, Mathis D: Mast cells in autoimmune disease. Nature. 2002, 420: 875-878. 10.1038/nature01324.PubMed Benoist C, Mathis D: Mast cells in autoimmune disease. Nature. 2002, 420: 875-878. 10.1038/nature01324.PubMed
87.
go back to reference Murakami M, Hirano T: The pathological and physiological roles of IL-6 amplifier activation. Int J Biol Sci. 2012, 8: 1267-1280.PubMedCentralPubMed Murakami M, Hirano T: The pathological and physiological roles of IL-6 amplifier activation. Int J Biol Sci. 2012, 8: 1267-1280.PubMedCentralPubMed
88.
go back to reference Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G: The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol. 2012, 22: 557-566. 10.1016/j.tcb.2012.08.001.PubMed Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G: The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol. 2012, 22: 557-566. 10.1016/j.tcb.2012.08.001.PubMed
89.
go back to reference Wrigley BJ, Lip GY, Shantsila E: The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail. 2011, 13: 1161-1171. 10.1093/eurjhf/hfr122.PubMed Wrigley BJ, Lip GY, Shantsila E: The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail. 2011, 13: 1161-1171. 10.1093/eurjhf/hfr122.PubMed
90.
go back to reference Ronco C, Cicoira M, McCullough PA: Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol. 2012, 60: 1031-1042. 10.1016/j.jacc.2012.01.077.PubMed Ronco C, Cicoira M, McCullough PA: Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol. 2012, 60: 1031-1042. 10.1016/j.jacc.2012.01.077.PubMed
91.
go back to reference Torre-Amione G: Immune activation in chronic heart failure. Am J Cardiol. 2005, 95: 3C-8C. discussion 38C-40CPubMed Torre-Amione G: Immune activation in chronic heart failure. Am J Cardiol. 2005, 95: 3C-8C. discussion 38C-40CPubMed
92.
go back to reference Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nordoy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L: Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999, 83: 376-382. 10.1016/S0002-9149(98)00872-8.PubMed Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nordoy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L: Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999, 83: 376-382. 10.1016/S0002-9149(98)00872-8.PubMed
93.
go back to reference Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL: Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001, 103: 2055-2059. 10.1161/01.CIR.103.16.2055.PubMed Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL: Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001, 103: 2055-2059. 10.1161/01.CIR.103.16.2055.PubMed
94.
go back to reference Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA: PICARD study group: plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 2004, 65: 1357-1365. 10.1111/j.1523-1755.2004.00512.x.PubMed Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA: PICARD study group: plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 2004, 65: 1357-1365. 10.1111/j.1523-1755.2004.00512.x.PubMed
95.
go back to reference Prabhu SD: Cytokine-induced modulation of cardiac function. Circ Res. 2004, 95: 1140-1153. 10.1161/01.RES.0000150734.79804.92.PubMed Prabhu SD: Cytokine-induced modulation of cardiac function. Circ Res. 2004, 95: 1140-1153. 10.1161/01.RES.0000150734.79804.92.PubMed
96.
go back to reference Zager RA, Johnson AC, Lund S: Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury. Am J Physiol Renal Physiol. 2009, 297: F961-F970. 10.1152/ajprenal.00381.2009.PubMedCentralPubMed Zager RA, Johnson AC, Lund S: Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury. Am J Physiol Renal Physiol. 2009, 297: F961-F970. 10.1152/ajprenal.00381.2009.PubMedCentralPubMed
97.
go back to reference Kingma JG, Vincent C, Rouleau JR, Kingma I: Influence of acute renal failure on coronary vasoregulation in dogs. J Am Soc Nephrol. 2006, 17: 1316-1324. 10.1681/ASN.2005101084.PubMed Kingma JG, Vincent C, Rouleau JR, Kingma I: Influence of acute renal failure on coronary vasoregulation in dogs. J Am Soc Nephrol. 2006, 17: 1316-1324. 10.1681/ASN.2005101084.PubMed
98.
go back to reference Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, Andre S, Crijns HJ, Gabius HJ, Maessen J, Pinto YM: Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004, 110: 3121-3128. 10.1161/01.CIR.0000147181.65298.4D.PubMed Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, Andre S, Crijns HJ, Gabius HJ, Maessen J, Pinto YM: Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004, 110: 3121-3128. 10.1161/01.CIR.0000147181.65298.4D.PubMed
99.
go back to reference Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B: The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J. 2005, 26: 11-17.PubMed Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B: The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J. 2005, 26: 11-17.PubMed
100.
go back to reference Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 1992, 10: 267-293. 10.1146/annurev.iy.10.040192.001411.PubMed Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 1992, 10: 267-293. 10.1146/annurev.iy.10.040192.001411.PubMed
101.
102.
go back to reference Igney FH, Krammer PH: Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002, 2: 277-288. 10.1038/nrc776.PubMed Igney FH, Krammer PH: Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002, 2: 277-288. 10.1038/nrc776.PubMed
103.
go back to reference Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995, 81: 505-512. 10.1016/0092-8674(95)90071-3.PubMed Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995, 81: 505-512. 10.1016/0092-8674(95)90071-3.PubMed
104.
go back to reference Ashkenazi A, Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999, 11: 255-260. 10.1016/S0955-0674(99)80034-9.PubMed Ashkenazi A, Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999, 11: 255-260. 10.1016/S0955-0674(99)80034-9.PubMed
105.
go back to reference Thorburn A: Death receptor-induced cell killing. Cell Signal. 2004, 16: 139-144. 10.1016/j.cellsig.2003.08.007.PubMed Thorburn A: Death receptor-induced cell killing. Cell Signal. 2004, 16: 139-144. 10.1016/j.cellsig.2003.08.007.PubMed
106.
go back to reference Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A: Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol. 2008, 19: 1634-1642. 10.1681/ASN.2007121336.PubMed Sanz AB, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A: Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol. 2008, 19: 1634-1642. 10.1681/ASN.2007121336.PubMed
107.
go back to reference Riedl SJ, Salvesen GS: The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol. 2007, 8: 405-413.PubMed Riedl SJ, Salvesen GS: The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol. 2007, 8: 405-413.PubMed
108.
go back to reference Green DR, Kroemer G: The pathophysiology of mitochondrial cell death. Science. 2004, 305: 626-629. 10.1126/science.1099320.PubMed Green DR, Kroemer G: The pathophysiology of mitochondrial cell death. Science. 2004, 305: 626-629. 10.1126/science.1099320.PubMed
109.
110.
go back to reference Kaushal GP: Role of caspases in renal tubular epithelial cell injury. Semin Nephrol. 2003, 23: 425-431. 10.1016/S0270-9295(03)00086-X.PubMed Kaushal GP: Role of caspases in renal tubular epithelial cell injury. Semin Nephrol. 2003, 23: 425-431. 10.1016/S0270-9295(03)00086-X.PubMed
111.
go back to reference Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia–reperfusion. J Am Soc Nephrol. 2004, 15: 2115-2124. 10.1097/01.ASN.0000135059.67385.5D.PubMed Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia–reperfusion. J Am Soc Nephrol. 2004, 15: 2115-2124. 10.1097/01.ASN.0000135059.67385.5D.PubMed
112.
go back to reference Vijayan A, Martin DR, Sadow JL, Kissane J, Miller SB: Hepatocyte growth factor inhibits apoptosis after ischemic renal injury in rats. Am J Kidney Dis. 2001, 38: 274-278. 10.1053/ajkd.2001.26087.PubMed Vijayan A, Martin DR, Sadow JL, Kissane J, Miller SB: Hepatocyte growth factor inhibits apoptosis after ischemic renal injury in rats. Am J Kidney Dis. 2001, 38: 274-278. 10.1053/ajkd.2001.26087.PubMed
113.
go back to reference Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, Pike M, Guler HP: Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int. 1999, 55: 2423-2432. 10.1046/j.1523-1755.1999.00463.x.PubMed Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, Pike M, Guler HP: Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int. 1999, 55: 2423-2432. 10.1046/j.1523-1755.1999.00463.x.PubMed
114.
go back to reference Hladunewich MA, Corrigan G, Derby GC, Ramaswamy D, Kambham N, Scandling JD, Myers BD: A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF. Kidney Int. 2003, 64: 593-602. 10.1046/j.1523-1755.2003.00100.x.PubMed Hladunewich MA, Corrigan G, Derby GC, Ramaswamy D, Kambham N, Scandling JD, Myers BD: A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF. Kidney Int. 2003, 64: 593-602. 10.1046/j.1523-1755.2003.00100.x.PubMed
115.
go back to reference Virzi GM, de Cal M, Cruz DN, Bolin C, Vescovo G, Ronco C: [Type 1 cardiorenal syndrome and its possible pathophysiological mechanisms]. G Ital Nefrol. 2012, 29: 690-698.PubMed Virzi GM, de Cal M, Cruz DN, Bolin C, Vescovo G, Ronco C: [Type 1 cardiorenal syndrome and its possible pathophysiological mechanisms]. G Ital Nefrol. 2012, 29: 690-698.PubMed
116.
go back to reference Virzi GM, Torregrossa R, Cruz DN, Chionh CY, de Cal M, Soni SS, Dominici M, Vescovo G, Rosner MH, Ronco C: Cardiorenal syndrome type 1 may be immunologically mediated: a pilot evaluation of monocyte apoptosis. Cardiorenal Med. 2012, 2: 33-42. 10.1159/000335499.PubMedCentralPubMed Virzi GM, Torregrossa R, Cruz DN, Chionh CY, de Cal M, Soni SS, Dominici M, Vescovo G, Rosner MH, Ronco C: Cardiorenal syndrome type 1 may be immunologically mediated: a pilot evaluation of monocyte apoptosis. Cardiorenal Med. 2012, 2: 33-42. 10.1159/000335499.PubMedCentralPubMed
117.
go back to reference Anker SD, Coats AJ: How to recover from renaissance? The significance of the results of recover, renaissance, renewal and attach. Int J Cardiol. 2002, 86: 123-130. 10.1016/S0167-5273(02)00470-9.PubMed Anker SD, Coats AJ: How to recover from renaissance? The significance of the results of recover, renaissance, renewal and attach. Int J Cardiol. 2002, 86: 123-130. 10.1016/S0167-5273(02)00470-9.PubMed
118.
go back to reference Momii H, Shimokawa H, Oyama J, Cheng XS, Nakamura R, Egashira K, Nakazawa H, Takeshita A: Inhibition of adhesion molecules markedly ameliorates cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Mol Cell Cardiol. 1998, 30: 2637-2650. 10.1006/jmcc.1998.0820.PubMed Momii H, Shimokawa H, Oyama J, Cheng XS, Nakamura R, Egashira K, Nakazawa H, Takeshita A: Inhibition of adhesion molecules markedly ameliorates cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Mol Cell Cardiol. 1998, 30: 2637-2650. 10.1006/jmcc.1998.0820.PubMed
119.
go back to reference Daemen MA, Van’t Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 1999, 104: 541-549. 10.1172/JCI6974.PubMedCentralPubMed Daemen MA, Van’t Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 1999, 104: 541-549. 10.1172/JCI6974.PubMedCentralPubMed
120.
go back to reference Kelly KJ, Meehan SM, Colvin RB, Williams WW, Bonventre JV: Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody. Kidney Int. 1999, 56: 922-931. 10.1046/j.1523-1755.1999.00629.x.PubMed Kelly KJ, Meehan SM, Colvin RB, Williams WW, Bonventre JV: Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody. Kidney Int. 1999, 56: 922-931. 10.1046/j.1523-1755.1999.00629.x.PubMed
121.
go back to reference Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, Sabbadini RA: Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996, 98: 2854-2865. 10.1172/JCI119114.PubMedCentralPubMed Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, Sabbadini RA: Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996, 98: 2854-2865. 10.1172/JCI119114.PubMedCentralPubMed
122.
go back to reference Muller-Werdan U, Schumann H, Fuchs R, Reithmann C, Loppnow H, Koch S, Zimny-Arndt U, He C, Darmer D, Jungblut P, Stadler J, Holtz J, Werdan K: Tumor necrosis factor alpha (TNF alpha) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity. J Mol Cell Cardiol. 1997, 29: 2915-2923. 10.1006/jmcc.1997.0526.PubMed Muller-Werdan U, Schumann H, Fuchs R, Reithmann C, Loppnow H, Koch S, Zimny-Arndt U, He C, Darmer D, Jungblut P, Stadler J, Holtz J, Werdan K: Tumor necrosis factor alpha (TNF alpha) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity. J Mol Cell Cardiol. 1997, 29: 2915-2923. 10.1006/jmcc.1997.0526.PubMed
123.
go back to reference Patten M, Kramer E, Bunemann J, Wenck C, Thoenes M, Wieland T, Long C: Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo. Pflugers Arch. 2001, 442: 920-927. 10.1007/s004240100612.PubMed Patten M, Kramer E, Bunemann J, Wenck C, Thoenes M, Wieland T, Long C: Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo. Pflugers Arch. 2001, 442: 920-927. 10.1007/s004240100612.PubMed
125.
go back to reference Soni SS, Ronco C, Pophale R, Bhansali AS, Nagarik AP, Barnela SR, Saboo SS, Raman A: Cardio-renal syndrome type 5: epidemiology, pathophysiology, and treatment. Semin Nephrol. 2012, 32: 49-56. 10.1016/j.semnephrol.2011.11.007.PubMed Soni SS, Ronco C, Pophale R, Bhansali AS, Nagarik AP, Barnela SR, Saboo SS, Raman A: Cardio-renal syndrome type 5: epidemiology, pathophysiology, and treatment. Semin Nephrol. 2012, 32: 49-56. 10.1016/j.semnephrol.2011.11.007.PubMed
126.
go back to reference Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C, McCullough PA, Kellum JA: Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol. 2013, 182: 174-194.PubMed Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C, McCullough PA, Kellum JA: Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol. 2013, 182: 174-194.PubMed
127.
go back to reference Srisawat N, Hoste EE, Kellum JA: Modern classification of acute kidney injury. Blood Purif. 2010, 29: 300-307. 10.1159/000280099.PubMed Srisawat N, Hoste EE, Kellum JA: Modern classification of acute kidney injury. Blood Purif. 2010, 29: 300-307. 10.1159/000280099.PubMed
128.
go back to reference Bagshaw SM, George C, Dinu I, Bellomo R: A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008, 23: 1203-1210.PubMed Bagshaw SM, George C, Dinu I, Bellomo R: A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008, 23: 1203-1210.PubMed
129.
go back to reference Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995, 273: 117-123. 10.1001/jama.1995.03520260039030.PubMed Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995, 273: 117-123. 10.1001/jama.1995.03520260039030.PubMed
130.
go back to reference Aziz M, Jacob A, Yang WL, Matsuda A, Wang P: Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol. 2013, 93: 329-342. 10.1189/jlb.0912437.PubMedCentralPubMed Aziz M, Jacob A, Yang WL, Matsuda A, Wang P: Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol. 2013, 93: 329-342. 10.1189/jlb.0912437.PubMedCentralPubMed
131.
go back to reference Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK: Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med. 2012, 40: 2997-3006. 10.1097/CCM.0b013e31825b912d.PubMed Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK: Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med. 2012, 40: 2997-3006. 10.1097/CCM.0b013e31825b912d.PubMed
132.
go back to reference Jacobs R, Honore PM, Joannes-Boyau O, Boer W, De Regt J, De Waele E, Collin V, Spapen HD: Septic acute kidney injury: the culprit is inflammatory apoptosis rather than ischemic necrosis. Blood Purif. 2011, 32: 262-265. 10.1159/000330244.PubMed Jacobs R, Honore PM, Joannes-Boyau O, Boer W, De Regt J, De Waele E, Collin V, Spapen HD: Septic acute kidney injury: the culprit is inflammatory apoptosis rather than ischemic necrosis. Blood Purif. 2011, 32: 262-265. 10.1159/000330244.PubMed
133.
go back to reference Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, Jarman S, Efimov IR, Janks DL, Srivastava A, Bhayani SB, Drewry A, Swanson PE, Hotchkiss RS: Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med. 2013, 187: 509-517. 10.1164/rccm.201211-1983OC.PubMedCentralPubMed Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, Jarman S, Efimov IR, Janks DL, Srivastava A, Bhayani SB, Drewry A, Swanson PE, Hotchkiss RS: Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med. 2013, 187: 509-517. 10.1164/rccm.201211-1983OC.PubMedCentralPubMed
134.
go back to reference Balija TM, Lowry SF: Lipopolysaccharide and sepsis-associated myocardial dysfunction. Curr Opin Infect Dis. 2011, 24: 248-253. 10.1097/QCO.0b013e32834536ce.PubMed Balija TM, Lowry SF: Lipopolysaccharide and sepsis-associated myocardial dysfunction. Curr Opin Infect Dis. 2011, 24: 248-253. 10.1097/QCO.0b013e32834536ce.PubMed
135.
go back to reference Buerke U, Carter JM, Schlitt A, Russ M, Schmidt H, Sibelius U, Grandel U, Grimminger F, Seeger W, Mueller-Werdan U, Werdan K, Buerke M: Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock. 2008, 29: 497-503. 10.1097/SHK.0b013e318142c434.PubMed Buerke U, Carter JM, Schlitt A, Russ M, Schmidt H, Sibelius U, Grandel U, Grimminger F, Seeger W, Mueller-Werdan U, Werdan K, Buerke M: Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock. 2008, 29: 497-503. 10.1097/SHK.0b013e318142c434.PubMed
136.
go back to reference Merx MW, Weber C: Sepsis and the heart. Circulation. 2007, 116: 793-802. 10.1161/CIRCULATIONAHA.106.678359.PubMed Merx MW, Weber C: Sepsis and the heart. Circulation. 2007, 116: 793-802. 10.1161/CIRCULATIONAHA.106.678359.PubMed
137.
go back to reference Oudemans-van Straaten HM: Circulating pro-apoptotic mediators in burn septic acute renal failure. Crit Care. 2008, 12: 126-10.1186/cc6798.PubMedCentralPubMed Oudemans-van Straaten HM: Circulating pro-apoptotic mediators in burn septic acute renal failure. Crit Care. 2008, 12: 126-10.1186/cc6798.PubMedCentralPubMed
138.
go back to reference Cantaluppi V, Assenzio B, Pasero D, Romanazzi GM, Pacitti A, Lanfranco G, Puntorieri V, Martin EL, Mascia L, Monti G, Casella G, Segoloni GP, Camussi G, Ranieri VM: Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med. 2008, 34: 1638-1645. 10.1007/s00134-008-1124-6.PubMedCentralPubMed Cantaluppi V, Assenzio B, Pasero D, Romanazzi GM, Pacitti A, Lanfranco G, Puntorieri V, Martin EL, Mascia L, Monti G, Casella G, Segoloni GP, Camussi G, Ranieri VM: Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med. 2008, 34: 1638-1645. 10.1007/s00134-008-1124-6.PubMedCentralPubMed
139.
go back to reference Mariano F, Cantaluppi V, Stella M, Romanazzi GM, Assenzio B, Cairo M, Biancone L, Triolo G, Ranieri VM, Camussi G: Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care. 2008, 12: R42-10.1186/cc6848.PubMedCentralPubMed Mariano F, Cantaluppi V, Stella M, Romanazzi GM, Assenzio B, Cairo M, Biancone L, Triolo G, Ranieri VM, Camussi G: Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care. 2008, 12: R42-10.1186/cc6848.PubMedCentralPubMed
140.
go back to reference Kockara A, Kayatas M: Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury. Ren Fail. 2013, 35: 291-294. 10.3109/0886022X.2012.744040.PubMed Kockara A, Kayatas M: Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury. Ren Fail. 2013, 35: 291-294. 10.3109/0886022X.2012.744040.PubMed
141.
go back to reference Lerolle N, Nochy D, Guerot E, Bruneval P, Fagon JY, Diehl JL, Hill G: Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med. 2010, 36: 471-478. 10.1007/s00134-009-1723-x.PubMed Lerolle N, Nochy D, Guerot E, Bruneval P, Fagon JY, Diehl JL, Hill G: Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med. 2010, 36: 471-478. 10.1007/s00134-009-1723-x.PubMed
142.
go back to reference Celes MR, Prado CM, Rossi MA: Sepsis: going to the heart of the matter. Pathobiology. 2013, 80: 70-86. 10.1159/000341640.PubMed Celes MR, Prado CM, Rossi MA: Sepsis: going to the heart of the matter. Pathobiology. 2013, 80: 70-86. 10.1159/000341640.PubMed
143.
go back to reference Cantaluppi V, Weber V, Lauritano C, Figliolini F, Beltramo S, Biancone L, De Cal M, Cruz D, Ronco C, Segoloni GP, Tetta C, Camussi G: Protective effect of resin adsorption on septic plasma-induced tubular injury. Crit Care. 2010, 14: R4-10.1186/cc8835.PubMedCentralPubMed Cantaluppi V, Weber V, Lauritano C, Figliolini F, Beltramo S, Biancone L, De Cal M, Cruz D, Ronco C, Segoloni GP, Tetta C, Camussi G: Protective effect of resin adsorption on septic plasma-induced tubular injury. Crit Care. 2010, 14: R4-10.1186/cc8835.PubMedCentralPubMed
144.
go back to reference Novaes AB, de Uzeda M, Fonseca ME, Feitosa AC: The effect of subinhibitory concentrations of metronidazole and tetracycline on the ultrastructure of periodontopathic bacteria. J Antimicrob Chemother. 1991, 28: 151-154. 10.1093/jac/28.1.151.PubMed Novaes AB, de Uzeda M, Fonseca ME, Feitosa AC: The effect of subinhibitory concentrations of metronidazole and tetracycline on the ultrastructure of periodontopathic bacteria. J Antimicrob Chemother. 1991, 28: 151-154. 10.1093/jac/28.1.151.PubMed
145.
go back to reference Horton JW, Maass D, White J, Sanders B: Nitric oxide modulation of TNF-alpha-induced cardiac contractile dysfunction is concentration dependent. Am J Physiol Heart Circ Physiol. 2000, 278: H1955-H1965.PubMed Horton JW, Maass D, White J, Sanders B: Nitric oxide modulation of TNF-alpha-induced cardiac contractile dysfunction is concentration dependent. Am J Physiol Heart Circ Physiol. 2000, 278: H1955-H1965.PubMed
146.
go back to reference Francis SE, Holden H, Holt CM, Duff GW: Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol. 1998, 30: 215-223. 10.1006/jmcc.1997.0592.PubMed Francis SE, Holden H, Holt CM, Duff GW: Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol. 1998, 30: 215-223. 10.1006/jmcc.1997.0592.PubMed
147.
go back to reference Mullonkal CJ, Toledo-Pereyra LH: Akt in ischemia and reperfusion. J Invest Surg. 2007, 20: 195-203. 10.1080/08941930701366471.PubMed Mullonkal CJ, Toledo-Pereyra LH: Akt in ischemia and reperfusion. J Invest Surg. 2007, 20: 195-203. 10.1080/08941930701366471.PubMed
Metadata
Title
Heart–kidney crosstalk and role of humoral signaling in critical illness
Authors
Grazia Maria Virzì
Sonya Day
Massimo de Cal
Giorgio Vescovo
Claudio Ronco
Publication date
01-02-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13177

Other articles of this Issue 1/2014

Critical Care 1/2014 Go to the issue